Prosecution Insights
Last updated: October 25, 2026

United One Law Group LLC

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

51 pending office actions • 29 clients • 44 examiners • 37 art units • 0 of 51 (0%) have an AI response strategy ready

Analysis

United One Law Group LLC has 51 pending office actions in Biotechnology & Pharmaceuticals and 767 career applications. The open docket is accompanied by a reported application base, allowing current workload to be considered in the context of recorded activity.

Its resolved allowance rate is 77.22%, and the average is 2.61 office actions per allowance. The figures indicate that resolved matters commonly involve multiple examination exchanges, while the allowance rate describes the reported proportion reaching an allowed result.

This profile is useful for prosecution planning because it joins workload, volume, and outcome information. Practitioners can use the measures to distinguish the demands of active matters from the historical performance reflected in resolved cases.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=767 apps, methodology: how we score firms)

77.2%
Allowance Rate
n=767
+0.30σ
Allowance Rate (norm)
n=767
2.6
OAs to Allowance
n=427
-0.52σ
OAs to Allow (norm)
n=427
843 days
Time to Allowance
n=427
+14.2pp
Interview Lift
n=767
23.0%
RCE Rate
n=767
0.0%
Appeal Rate
n=767

Rejection Performance (% of received rejections ultimately overcome)

38.6%
§101 Overcome
n=83
66.0%
§102 Overcome
n=279
59.5%
§103 Overcome
n=415
58.9%
§112 Overcome
n=287

Specialization & Scale

A61B, A61K, G06F
Top CPC Subclasses
14%
Top-3 CPC Share
n=767
2
Practitioners
n=767
383.5
Apps / Practitioner
n=767

Portfolio Summary

51
Total Pending OAs
31
Non-Final OAs
19
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
4
Due this month
3
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (4)Due ≤ 60 days (3)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

26
Hard (51%)
23
Medium (45%)
2
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only3 (6%)
§101 + other7 (14%)
§103 only16 (31%)
§102 only2 (4%)
§112 only2 (4%)
Double-patenting + other5 (10%)
Multi-statute (no §101)16 (31%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

30
Life Sciences
59% of docket
2
Information Tech
4% of docket
1
Communications
2% of docket
7
Semiconductors
14% of docket
11
Mechanical / Eng
22% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

510 h
Manual time on pending OAs
102 h
Time saved (low, 20%)
178 h
Time saved (mid, 35%)
4.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LIU, CHU CHUAN 4 71.3% +14.9%
CHEN, PO-CHIH 3 74.3% +14.7%
PEERCE, MATTHEW J 2 68.4% +26.5%
EGWIM, KELECHI CHIDI 2 69.7% +14.7%
NEGRON, ISMAEL 1 73.6% +15.1%
NGUYEN, HAIDUNG D 1 64.8% +28.1%
SUBRAMANIAN, VISWANATHAN 1 81.5% +19.3%
LEE, PAUL CHANG 1 75.1% +13.9%
BLACKSTEN, SYDNEY LYNN 1 100.0% +0.0%
PHILLIPS, FORREST M 1 83.2% +14.2%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19083141 SHAFT GROUNDING RING SUBRAMANIAN, VISWANATHAN —
18964878 DEVICE FOR PROCESSING DENTAL PROSTHESIS WITH REDUCED NOISE PHILLIPS, FORREST M —

Hard Cases (26)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17947527 FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS HERNANDEZ, JACKSON J 71d overdue
17239118 SYSTEM FOR EVALUATING SENSITIVITY TO ANTI-CANCER AGENT AND A COMPUTER READABLE MEDIUM STORING PROGRAMS EXECUTING AN EVALUATING METHOD AUGER, NOAH ANDREW 8d
18427912 RAMAN SPECTROSCOPY METHOD FOR BLOOD GLUCOSE MEASUREMENT LIU, CHU CHUAN 9d
19199728 VEHICLE LAMP PEERCE, MATTHEW J 27d
18322723 SURFACE-ENGINEERED EXTRACELLULAR VESICLES AND THERAPEUTIC USES THEREOF WILSON, MICHAEL C 29d
18171366 METHOD FOR PREPARING AZO COMPOUND SAWYER, JENNIFER C 34d
17692236 PRIMER SET FOR DETECTING FOOD POISONING BACTERIA BY USING NEXT-GENERATION SEQUENCING METHOD AND METHOD FOR DETECTING FOOD POISONING BACTERIA BY USING THE PRIMER SET OYEYEMI, OLAYINKA A 34d
18554245 VACCINE MANAGEMENT DEVICE AND VACCINE MANAGEMENT SYSTEM INCLUDING THE SAME, OPERATING METHOD OF VACCINE MANAGEMENT DEVICE AND METHOD FOR PROVIDING VACCINE HEALTHCARE SOLUTIONS EVANS, TRISTAN ISAAC 83d

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18427880 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING LINEAR VARIABLE FILTER LIU, CHU CHUAN 42d overdue
18427879 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING FILTER ARRAY LIU, CHU CHUAN 42d overdue
18427873 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY LIU, CHU CHUAN 1d overdue
18427912 RAMAN SPECTROSCOPY METHOD FOR BLOOD GLUCOSE MEASUREMENT LIU, CHU CHUAN 9d
19199728 VEHICLE LAMP PEERCE, MATTHEW J 27d
19044217 LIGHT-EMITTING MODULE AND VEHICLE LAMP COMPRISING SAME PEERCE, MATTHEW J 69d
19367552 VEHICLE LAMP NEGRON, ISMAEL —
19210245 CONDUCTIVE SLURRY FOR SECONDARY BATTERY ELECTRODE, SECONDARY BATTERY ELECTRODE, AND SECONDARY BATTERY COMPRISING SAME NGUYEN, HAIDUNG D —

Client Portfolio (29 clients)

Top Art Units

Art UnitApps
37915
28753
16213
17612
28712
16272
16232
17372
17622
28341

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19367552 VEHICLE LAMP Etendue Lighting Co., Ltd. NEGRON, ISMAEL 2875 §102§103§112 Non-Final OA — Pending Oct 23, 2025
19210245 CONDUCTIVE SLURRY FOR SECONDARY BATTERY ELECTRODE, SECONDARY BATTERY ELECTRODE, AND SECONDARY BATTERY COMPRISING SAME Dongjin Semichem Co., Ltd. NGUYEN, HAIDUNG D 1761 §102§103 Non-Final OA — Pending May 16, 2025
19199728 VEHICLE LAMP Sl Corporation PEERCE, MATTHEW J 2875 §102§103§112 Final Rejection 27d Pending May 06, 2025
19083141 SHAFT GROUNDING RING Dgenx Co., Ltd. SUBRAMANIAN, VISWANATHAN 2834 §102 Non-Final OA — Pending Mar 18, 2025
19044217 LIGHT-EMITTING MODULE AND VEHICLE LAMP COMPRISING SAME Sl Corporation PEERCE, MATTHEW J 2875 §103 Final Rejection 69d Pending Feb 03, 2025
19023835 APPARATUS FOR OPERATING MIRROR ASSEMBLY OF VEHICLE Sl Mirrortech Corporation LEE, PAUL CHANG 2871 §102 Non-Final OA — Pending Jan 16, 2025
19024318 DEVICE AND METHOD FOR GENERATING INFECTION STATE INFORMATION ON BASIS OF IMAGE INFORMATION Calth. Inc. BLACKSTEN, SYDNEY LYNN 2674 §103§112 Non-Final OA — Pending Jan 16, 2025
18964878 DEVICE FOR PROCESSING DENTAL PROSTHESIS WITH REDUCED NOISE Huvitz Co., Ltd. PHILLIPS, FORREST M 2837 §103 Non-Final OA — Pending Dec 02, 2024
18854158 APPARATUS AND METHOD FOR CONTROLLING AIR CONDITIONER USING COMFORTABLE TEMPERATURE AND SYSTEM COMPRISING THE APPARATUS Seedn Co., Ltd. KHATIB, RAMI 3669 §101§103§112 Non-Final OA — Pending Oct 23, 2024
18918365 FUNCTIONAL DERIVATIVE COMPOUNDS OF ALANINE AND PROLINE AMINO ACIDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Amtixbio Co., Ltd. CHEN, PO-CHIH 1621 §103Other Non-Final OA — Pending Oct 17, 2024
18918533 COMPOSITION AND METHODS FOR PREVENTING OR TREATING PHYTOPATHOGENIC FUNGAL INFECTION Amtixbio Co., Ltd. CHEN, PO-CHIH 1621 §101§103Other Non-Final OA — Pending Oct 17, 2024
18918511 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MYCOSIS Amtixbio Co., Ltd. CHEN, PO-CHIH 1621 §103§112Other Non-Final OA — Pending Oct 17, 2024
18565735 BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION Amtixbio Co., Ltd. WHITE, DAWANNA SHAR-DAY 1627 §102DP Non-Final OA — Pending Sep 27, 2024
18822009 HYPOIMMUNOGENIC STEM CELLS, HYPOIMMUNOGENIC CELLS DIFFERENTIATED OR DERIVED FROM STEM CELLS AND METHOD OF PREPARING SAME Toolgen Incorporated TINSLEY, BRENDAN THOMAS 1634 §101§102§103§112 Non-Final OA — Pending Aug 30, 2024
18801507 METHOD, SYSTEM, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR ESTIMATING ARRHYTHMIA USING ARTIFICIAL NEURAL NETWORKS Huinno Co., Ltd. LEE, ERICA SHENGKAI 3796 §101§103 Non-Final OA — Pending Aug 12, 2024
18749327 GRAPHITE OXIDE, GRAPHENE OXIDE, AND REDUCED GRAPHENE OXIDE Dongjin Semichem Co., Ltd. DAVIS, SHENG HAN 1732 §102§103§112 Non-Final OA — Pending Jun 20, 2024
18746908 CONDUCTIVE AGENT SLURRY FOR SECONDARY BATTERY ELECTRODE, SECONDARY BATTERY ELECTRODE INCLUDING SAME, AND SECONDARY BATTERY Dongjin Semichem Co., Ltd. NGUYEN, KHANH TUAN 1761 §103 Non-Final OA — Pending Jun 18, 2024
18739065 COMPOSITIONS AND METHODS FOR TREATING, PREVENTING, AND IMPROVING RESPIRATORY SYMPTOMS Efil Bioscience Inc. FIEBIG, RUSSELL G 1655 §103 Non-Final OA — Pending Jun 10, 2024
18678236 SOLAR CELL AND METHOD OF FORMING THE SAME Dongjin Semichem Co., Ltd. DINH, BACH T 1726 §103 Non-Final OA — Pending May 30, 2024
18677107 ESTROUS SENSOR IMPLANTABLE INTO BODY OF DOMESTIC ANIMAL AND ESTRUS DETERMINATION METHOD USING THE SAME Damoatech Co.,Ltd. HEALY, NOAH MICHAEL 3791 §103§112 Non-Final OA — Pending May 29, 2024
18654486 PHARMACEUTICAL COMPOSITION COMPRISING PI3K AND DNA-PK DUAL INHIBITOR FOR PREVENTING OR TREATING PERIPHERAL T CELL LYMPHOMA Boryung Corporation SHTERENGARTS, SAMANTHA L 1623 §103 Non-Final OA — Pending May 03, 2024
18620949 POSITIVE ELECTRODE ACTIVE MATERIAL COMPOSITE FOR BATTERY, SECONDARY BATTERY ELECTRODE, AND SECONDARY BATTERY Dongjin Semichem Co., Ltd. LUSTGRAAF, BENJAMIN T 1727 §102§103 Non-Final OA — Pending Mar 28, 2024
18606993 METHOD, SYSTEM, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR ESTIMATING ARRHYTHMIA USING COMPOSITE ARTIFICIAL NEURAL NETWORK Huinno, Co., Ltd. HODGE, LAURA NICOLE 3792 §101 Non-Final OA — Pending Mar 15, 2024
18601424 SELECTIVE INHIBITORS OF ROCK2 PROTEIN KINASES AND USES THEREOF Genosco Inc. BAUER, BRIANNA LEE 1623 §112 Non-Final OA — Pending Mar 11, 2024
18431934 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND DISPLAY DEVICE COMPRISING SAME Dongjin Semichem Co., Ltd. CHACKO DAVIS, DABORAH 1737 §102§103 Non-Final OA — Pending Feb 03, 2024
18427880 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING LINEAR VARIABLE FILTER Apollon Inc. LIU, CHU CHUAN 3791 §103DP Final Rejection 42d overdue Pending Jan 31, 2024
18427912 RAMAN SPECTROSCOPY METHOD FOR BLOOD GLUCOSE MEASUREMENT Apollon Inc. LIU, CHU CHUAN 3791 §103§112Other Non-Final OA 9d Pending Jan 31, 2024
18427879 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY COMPRISING FILTER ARRAY Apollon Inc. LIU, CHU CHUAN 3791 §103DP Final Rejection 42d overdue Pending Jan 31, 2024
18427873 APPARATUS FOR BLOOD GLUCOSE MEASUREMENT BASED ON RAMAN SPECTROSCOPY Apollon Inc. LIU, CHU CHUAN 3791 §103DP Final Rejection 1d overdue Pending Jan 31, 2024
18412934 METHOD, SYSTEM, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR MANAGING OUTPUT DATA OF BIOSIGNAL ANALYSIS MODEL Huinno, Co., Ltd. PATEL, SHERYL GOPAL 3685 §101 Final Rejection — Pending Jan 15, 2024
18512948 ORGANIC LAYER POLISHING COMPOSITION AND METHOD FOR POLISHING USING SAME Dongjin Semichem Co., Ltd. LU, JIONG-PING 1713 §103 Final Rejection — Pending Nov 17, 2023
18501740 COMPOSITION COMPRISING GLP-1 RECEPTOR AGONIST AND ACAT INHIBITOR Efil Bioscience Inc. D' AMBROSIO, THEA 1654 §103DP Final Rejection — Pending Nov 03, 2023
18554245 VACCINE MANAGEMENT DEVICE AND VACCINE MANAGEMENT SYSTEM INCLUDING THE SAME, OPERATING METHOD OF VACCINE MANAGEMENT DEVICE AND METHOD FOR PROVIDING VACCINE HEALTHCARE SOLUTIONS Real Time Medi Check Corp. EVANS, TRISTAN ISAAC 3683 §101 Final Rejection 83d Pending Oct 18, 2023
18552208 POLYESTER MASTER BATCH COMPOSITION, AND POLYESTER YARN CONTAINING SAME Heon Sang Kim EGWIM, KELECHI CHIDI 1762 §102§112 Non-Final OA — Pending Sep 25, 2023
18472485 SYSTEM AND METHOD FOR ENABLING A MULTI-OPERATOR EDGE ENVIRONMENT Indian Institute Of Technology Delhi MCBETH, WILLIAM C 2449 §103 Final Rejection 79d Pending Sep 22, 2023
18465328 TEMPEH CHIPS WITH IMPROVED ACID VALUE STABILITY AND METHOD OF MANUFACTURING THE SAME Mamame Whole Foods Pte. Ltd. GERLA, STEPHANIE RAE 1791 §103 Final Rejection 83d Pending Sep 12, 2023
18447152 METHOD FOR INDUCING RESOLUTIVE MACROPHAGE AND USES THEROF Shiftbio Inc. ALDARONDO, DASIA ALI 1647 §103 Final Rejection 17d overdue Pending Aug 09, 2023
18322723 SURFACE-ENGINEERED EXTRACELLULAR VESICLES AND THERAPEUTIC USES THEREOF Shiftbio Inc. WILSON, MICHAEL C 1638 §102§112Other Final Rejection 29d Pending May 24, 2023
17761809 USE OF GENE INVOLVED IN PASSAGE THROUGH BRAIN-BLOOD BARRIER AND SURVIVAL INSIDE BRAIN OF CAUSATIVE FUNGI OF MENINGOENCEPHALITIS Amtixbio Co., Ltd. KANE, TREVOR LOGAN 1657 §102§112 Non-Final OA — Pending Apr 15, 2023
18300852 NATURAL KILLER CELL HAVING CONTROLLED ONCOLOGY-RELEATED GENE EXPRESSION, AND USE THEREOF Cha Biolab Co., Ltd. GRABER, JAMES J 1631 §103 Final Rejection 34d Pending Apr 14, 2023
18179742 LOW-REFRACTIVE-INDEX THERMOSETTING COMPOSITION, OPTICAL MEMBER FORMED THEREFROM, AND DISPLAY DEVICE Dongjin Semichem Co., Ltd. STONEHOCKER, VIRGINIA LEE 1766 §103 Non-Final OA — Pending Mar 07, 2023
18171366 METHOD FOR PREPARING AZO COMPOUND Dongjin Innochem Co., Ltd. SAWYER, JENNIFER C 1691 §102§103 Final Rejection 34d Pending Feb 19, 2023
18167213 OPTICAL DEVICE FOR VEHICLE Sl Corporation NGUYEN, LAUREN 2871 §102§103 Final Rejection — Pending Feb 10, 2023
18090313 COMPOUND, RESIST UNDERLAYER FILM COMPOSITION INCLUDING SAME, AND RESIST UNDERLAYER FILM Dongjin Semichem Co., Ltd. CHU, JOHN S Y 1737 §102§112 Final Rejection — Pending Dec 28, 2022
18089140 POLYIMIDE-BASED COMPOSITION AND POLYIMIDE FILM Dongjin Semichem Co., Ltd. EGWIM, KELECHI CHIDI 1762 §103 Non-Final OA — Pending Dec 27, 2022
17947527 FUSED HETEROCYCLIC RINGS AS RIPK1 INHIBITORS BISICHEM CO., LTD. HERNANDEZ, JACKSON J 1627 §101§112 Non-Final OA 71d overdue Pending Sep 19, 2022
17862315 MICRONEEDLE, MICROCONE, AND PHOTOLITHOGRAPHY FABRICATION METHODS Raphas Co., Ltd. FREHE, WILLIAM R 3783 §103 Final Rejection 17d overdue Pending Jul 11, 2022
17692236 PRIMER SET FOR DETECTING FOOD POISONING BACTERIA BY USING NEXT-GENERATION SEQUENCING METHOD AND METHOD FOR DETECTING FOOD POISONING BACTERIA BY USING THE PRIMER SET Korean Ministry Of Food And Drug Safety OYEYEMI, OLAYINKA A 1681 §101§103 Non-Final OA 34d Pending Mar 11, 2022
17574227 ANTI-TAU ANTIBODY AND USE OF SAME Adel, Inc. CHERNYSHEV, OLGA N 1675 §112 Final Rejection — Pending Jan 12, 2022
17387237 METHOD FOR RESPONDING TO THREAT TRANSMITTED THROUGH COMMUNICATION NETWORK Logpresso Inc. ABDULLAH, SAAD AHMAD 2431 §103 Non-Final OA — Pending Jul 28, 2021

View all 51 →

Managing United One Law Group LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is United One Law Group LLC's patent allowance rate?

77.2% of resolved applications prosecuted by United One Law Group LLC were allowed, across 767 applications in USPTO records.

How many office actions does United One Law Group LLC average before allowance?

2.61 office actions per allowed application on average.

How many pending office actions does United One Law Group LLC have?

51 pending office actions as of October 2026, for 29 clients, before 44 examiners in 37 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month